Silence Therapeutics plc (SLN) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts SLN Hot Sheet
Join SI Premium – FREE
Silence Therapeutics plc (NASDAQ: SLN) reported Q2 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Silence Therapeutics plc (SLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microsoft plans data center push to triple its computing power - Bloomberg
- RH (RH) Tops Q2 EPS by $2.31
- Lightpath Technologies (LPTH) Misses Q4 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
